FDA Orange Book · active-ingredient family
Benzgalantamine gluconate
Benzgalantamine gluconate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ZUNVEYL · NDA 218549
1
Brand (NDA)
0
Generics (ANDA)
4
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, delayed release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZUNVEYLRLD×3 | ALPHA COGNITION | NDA 218549 | — | Jul 26, 2024 |
Listed patents (4)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9763953 | Dec 01, 2026 | in 6 mo | U-713 |
| 11795176 | Jan 13, 2042 | in 15 yr 10 mo | SubstanceU-713 |
| 12208167 | Feb 26, 2044 | in 17 yr 11 mo | ProductU-713 |
| 12551491 | Jul 23, 2045 | in 19 yr 4 mo | U-713 |
Benzgalantamine gluconate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

